Effect of Recombinant Human Erythropoietin on Human IgE Production in Vitro

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1991 Mar 1

PMID 2004487

Citations 7

Authors

H Kimata

A Yoshida

C Ishioka

H MIKAWA

Affiliations

Soon will be listed here.

Abstract

Recombinant human erythropoietin enhanced spontaneous IgE production (200-300% enhancement) in cultures of peripheral blood mononuclear cells (MNC) from atopic patients. In contrast, IgG and IgA production were only slightly enhanced (30-50% enhancement), and IgM production was not affected by erythropoietin. The enhancement of IgE production by erythropoietin was indirect since it required T cells and monocytes. However, erythropoietin effect was specific since enhancement was blocked by anti-erythropoietin antibody but not by control antibody. Interleukin-4 (IL-4) also enhanced spontaneous IgE production from atopic MNC. However, the enhancing effect by erythropoietin is different from that by IL-4, since the erythropoietin effect was not blocked by anti-IL-4 antibody, and conversely IL-4 effect was not blocked by anti-erythropoietin antibody. In contrast to the enhancing effect on atopic MNC, erythropoietin failed to induce IgE production in cultures of MNC from normal donors while IL-4 induced IgE production from normal MNC. However, when normal MNC were pre-incubated with IL-4, erythropoietin enhanced IgE production from IL-4-pre-incubated MNC. Moreover, B cells separated from IL-4-pre-incubated MNC produced IgE which was enhanced by erythropoietin. However, this effect required T cells and monocytes. These results indicate that erythropoietin could regulate ongoing IgE production in vitro by T cell- and monocyte-dependent mechanisms.

Citing Articles

EpoR-tdTomato-Cre mice enable identification of EpoR expression in subsets of tissue macrophages and hematopoietic cells.

Zhang H, Wang S, Liu D, Gao C, Han Y, Guo X Blood. 2021; 138(20):1986-1997.

PMID: 34098576 PMC: 8767788. DOI: 10.1182/blood.2021011410.

Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

Peeters H, Jongen-Lavrencic M, Vreugdenhil G, Swaak A Ann Rheum Dis. 1996; 55(10):739-44.

PMID: 8984939 PMC: 1010292. DOI: 10.1136/ard.55.10.739.

RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells.

Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K J Exp Med. 1996; 183(5):2397-402.

PMID: 8642352 PMC: 2192590. DOI: 10.1084/jem.183.5.2397.

Detection of plasma interleukin-8 in atopic dermatitis.

Kimata H, Lindley I Arch Dis Child. 1994; 70(2):119-22.

PMID: 8129432 PMC: 1029713. DOI: 10.1136/adc.70.2.119.

Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells.

Kimata H, Fujimoto M J Exp Med. 1994; 180(2):727-32.

PMID: 8046348 PMC: 2191604. DOI: 10.1084/jem.180.2.727.

References

Goto M, Murakami A, Akai K, Kawanishi G, Ueda M, Chiba H . Characterization and use of monoclonal antibodies directed against human erythropoietin that recognize different antigenic determinants. Blood. 1989; 74(4):1415-23. View

Geissler K, Stockenhuber F, Kabrna E, Hinterberger W, Balcke P, Lechner K . Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. Blood. 1989; 73(8):2229. View

Vercelli D, Jabara H, Lauener R, Geha R . IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol. 1990; 144(2):570-3. View

Thiele D, Kurosaka M, Lipsky P . Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol. 1983; 131(5):2282-90. View

Kimata H, Shanahan F, Brogan M, Targan S, Saxon A . Modulation of ongoing human immunoglobulin synthesis by natural killer cells. Cell Immunol. 1987; 107(1):74-88. DOI: 10.1016/0008-8749(87)90267-x. View

Sherr E, Stein L, Dosch H, Saxon A . IgE-enhancing activity directly and selectively affects activated B cells: evidence for a human IgE differentiation factor. J Immunol. 1987; 138(11):3836-43. View

Defrance T, Aubry J, Rousset F, Vanbervliet B, Bonnefoy J, Arai N . Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med. 1987; 165(6):1459-67. PMC: 2188364. DOI: 10.1084/jem.165.6.1459. View

Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D . IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol. 1988; 140(12):4193-8. View

Pene J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy J . Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol. 1988; 18(6):929-35. DOI: 10.1002/eji.1830180615. View

10.

Kimata H, Saxon A . Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function. J Clin Invest. 1988; 82(1):160-7. PMC: 303490. DOI: 10.1172/JCI113565. View

11.

Pene J, Rousset F, Briere F, Chretien I, Bonnefoy J, Spits H . IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 1988; 85(18):6880-4. PMC: 282082. DOI: 10.1073/pnas.85.18.6880. View

12.

Sarfati M, Delespesse G . Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J Immunol. 1988; 141(7):2195-9. View

13.

Miyazaki H, Kozutsumi H, Kato T, Hoshi S, Tamura S, Kubota M . Production of monoclonal antibodies against human erythropoietin and their use in the purification of human urinary erythropoietin. J Immunol Methods. 1988; 113(2):261-7. DOI: 10.1016/0022-1759(88)90340-7. View

14.

Sawyer S, Krantz S, Sawada K . Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood. 1989; 74(1):103-9. View

15.

Asano Y, Okamura S, Shibuya T, Harada M, Niho Y . Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood. 1988; 72(5):1682-6. View

16.

Kimata H, Sherr E, Saxon A . Human natural killer (NK) cells produce a late-acting B-cell differentiation activity. J Clin Immunol. 1988; 8(5):381-9. DOI: 10.1007/BF00917154. View

17.

Fraser J, Tan A, Lin F, Berridge M . Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp Hematol. 1989; 17(1):10-6. View

18.

Yang X, de Weck A, Stadler B . Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis. Eur J Immunol. 1988; 18(11):1699-704. DOI: 10.1002/eji.1830181107. View

19.

Sherr E, Macy E, Kimata H, GILLY M, Saxon A . Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J Immunol. 1989; 142(2):481-9. View

20.

Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S . Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. Blood. 1989; 73(7):1828-35. View